UniProtKB/Swiss-Prot Q14934: Variant p.Gly160Ala

Nuclear factor of activated T-cells, cytoplasmic 4
Gene: NFATC4
Feedback?

Variant information Variant position:

160 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glycine (G) to Alanine (A) at position 160 (G160A, p.Gly160Ala). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from glycine (G) to small size and hydrophobic (A) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs2229309 [ dbSNP | Ensembl ]

Sequence information Variant position:

160 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

902 The length of the canonical sequence.
Location on the sequence:

DGSPRDYPPPEGFGGYREAG G QGGGAFFSPSPGSSSLSSWS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         DGSPRDYPPPEGFGGYREAGGQGGGAFFSPSPGSSSLSSWS

Mouse                         DGSPRDYPPPEGFGGYREAGGQGGGAFFSPSPGSSSLSSWS

Rat                           DGSPRDYPPPEGFGGYREAGGQGGGAFFSPSPGSSSLSSWS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 902	Nuclear factor of activated T-cells, cytoplasmic 4
Region	16 – 180	Disordered
Modified residue	168 – 168	Phosphoserine; by MAPK7 and MAPK14
Modified residue	170 – 170	Phosphoserine; by MAPK7 and MAPK14
Alternative sequence	1 – 712	Missing. In isoform 22, isoform 23 and isoform 24.
Alternative sequence	1 – 465	Missing. In isoform 19, isoform 20 and isoform 21.
Mutagenesis	168 – 168	S -> A. Promotes nuclear localization and increases transcriptional activity; when associated with A-170.
Mutagenesis	170 – 170	S -> A. Promotes nuclear localization and increases transcriptional activity; when associated with A-168.

Literature citations
Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins.
Hoey T.; Sun Y.-L.; Williamson K.; Xu X.;
Immunity 2:461-472(1995)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); FUNCTION; SUBUNIT; VARIANTS ALA-160 AND PRO-800; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1); NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 61-902 (ISOFORMS 1/2/4/6); VARIANTS ALA-160 AND PRO-800;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.